Adamant Biomedical Investments AG

13F Filings History

Latest 13F report: Q4 2014 - Feb 13, 2015
Value $: $418M
Signature - Title: Dr. Cyrill Zimmerman - CEO
Location: Zurich, Switzerland
Summary: This page shows a list of all the recent 13F filings made by Adamant Biomedical Investments AG. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Adamant Biomedical Investments AG reported 101 stock holdings with total value $418M as of Q4 2014. Top holdings included CELG, BIIB, GILD, AMGN, and B108PS.

Holdings Value

Quarter	Holdings	Value $	Bought	Sold	Net	Top Holdings	Form Type	Date Filed
Q4 2014	101	$418M	+$52.4M	-$73.5M	-$21.1M	CELG, BIIB, GILD, AMGN, B108PS	13F-HR	2/13/2015, 04:29 PM
Q3 2014	96	$391M	$0	$0		GILD, CELG, BIIB, AMGN, B108PS	13F-HR	11/14/2014, 03:18 PM
Q2 2014	0						13F-NT	8/7/2014, 10:04 AM
Q1 2014	0						13F-NT	4/29/2014, 11:31 AM
Q4 2013	0						13F-NT	2/3/2014, 03:46 PM